Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | AMT |
| Upstream (Parents) |
|---|
| (<<) MSRA → AMT |
| (<<) ALDH2 → AMT |
| (<<) SLC25A20 → AMT |
| (<<) HAGH → AMT |
| Downstream (Children) |
|---|
| AMT → ATF7IP2 (>>) |
| AMT → GLI2 (>>) |
| AMT → LOC283079 (>>) |
| AMT → IL4 (>>) |
| AMT → SERPINA2 (>>) |
| AMT → FAM163A (>>) |
| AMT → SIM1 (>>) |
| AMT → ARF1P1 (>>) |
| AMT → PAPPA (>>) |
| AMT → PHF8 (>>) |
| AMT → HTR7P1///HTR7 (>>) |
| AMT → MSL3 (>>) |
| AMT → RPL31 (>>) |
| AMT → ECH1 (>>) |
